Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

319
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
319
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Survival Tree01:19

Survival Tree

464
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
464
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

334
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
334
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

1.3K
Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
1.3K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

649
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
649

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value and Credibility of Meta-Analysis: Tutorial on Enhancing Methodological Rigor and AI-Powered Efficiency.

Journal of medical Internet research·2026
Same author

Re-Centering Clinical Documentation in the Age of AI Scribes: Four Aims of the Patient Chart Note.

JMIR medical education·2026
Same author

Co-intelligence: a proposal for human-artificial intelligence collaboration for large language models in medical research.

The Lancet. Digital health·2026
Same author

Artificial Intelligence in Peripheral Artery Disease: A Science Advisory From the American Heart Association.

Circulation. Population health and outcomes·2026
Same author

Physician-Reported Safety Outcomes of AI-Generated Hospital Course Summaries.

JAMA network open·2026
Same author

Employing Peer Outreach and Whole Health in Recovery (EMPOWER) for homeless-experienced veterans: protocol for a hybrid type 3 implementation trial.

Implementation science : IS·2026
Same journal

Digital divide in clinical and operational artificial intelligence adoption and implementation stages: US hospital diffusion patterns and AI deserts.

Journal of the American Medical Informatics Association : JAMIA·2026
Same journal

Extending the fundamental theorem of biomedical informatics: a proposal and illustrative examples.

Journal of the American Medical Informatics Association : JAMIA·2026
Same journal

Human factors methods for designing safe health information technology: what do the experts think?

Journal of the American Medical Informatics Association : JAMIA·2026
Same journal

Equity-by-design for socially assistive robots as digital health tools.

Journal of the American Medical Informatics Association : JAMIA·2026
Same journal

Orchestrator multi-agent clinical decision support system for secondary headache diagnosis in primary care.

Journal of the American Medical Informatics Association : JAMIA·2026
Same journal

CUI-Curate: a GraphRAG-based framework for automated clinical concept curation for NLP applications.

Journal of the American Medical Informatics Association : JAMIA·2026
See all related articles

Related Experiment Videos

Learning statistical models of phenotypes using noisy labeled training data.

Vibhu Agarwal1, Tanya Podchiyska2, Juan M Banda3

  • 1Biomedical Informatics Training Program, Stanford University, Stanford CA 94305-5479, USA vibhua@stanford.edu.

Journal of the American Medical Informatics Association : JAMIA
|May 14, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning method for electronic phenotyping using semi-automatically labeled data, accelerating the creation of patient phenotype models. The approach efficiently generates phenotype models from electronic health records, offering an alternative to time-consuming manual labeling.

Keywords:
Electronic health recordhigh throughputmachine learningnoisy labelsphenotyping

Related Experiment Videos

Area of Science:

  • Computational Health Informatics
  • Machine Learning in Healthcare
  • Electronic Health Records Research

Background:

  • Traditional patient phenotyping relies on labor-intensive rule-based definitions.
  • Machine learning for electronic phenotyping is hindered by limited labeled training data.

Purpose of the Study:

  • To demonstrate the feasibility of using semi-automatically labeled training sets for machine learning-based phenotype model creation.
  • To develop an efficient alternative to manual data labeling for phenotyping.

Main Methods:

  • Utilized a keyword list to generate noisy labeled training data for phenotypes.
  • Trained L1 penalized logistic regression models on comprehensive patient medical record data.
  • Evaluated model performance against a gold standard for chronic and acute diseases.

Main Results:

  • Achieved high precision and accuracy for Type 2 diabetes mellitus (0.90, 0.89) and myocardial infarction (0.86, 0.89) models.
  • Demonstrated the feasibility of learning phenotype models from imperfectly labeled data.
  • Model performance was comparable to validated rule-based definitions.

Conclusions:

  • The proposed method offers a viable alternative to manual labeling for creating statistical phenotype models.
  • This approach can expedite research utilizing large observational healthcare datasets.
  • The method facilitates the creation of local phenotype models efficiently.